BoyerN. H. (1943). Aminophylline and related xanthine derivatives. Present status of therapeutic claims: Report to Council of Pharmacy and Chemistry. J. Amer. med. Ass., 122, 306.
3.
BoyerN. H.GreenH. D. (1941). The effects of nitrites and xanthines on coronary inflow and blood pressure in anesthetized dogs. Amer. Heart J., 21, 199.
4.
BrownM. G.RisemanJ. E. F. (1937). The comparative value of purine derivatives in the treatment of angina pectoris. J. Amer. med. Ass., 109, 256.
5.
CronheimG. E.JusticeI. T.Jr.KingJ. S.Jr. (1953). New approach to increasing tolerance to oral aminophylline. Postgrad. Med., 13, 432.
6.
DietzeB. (1952). Behandlung angiospastischer Syndrome mit einem neuen wasserlöslichen Theophyllinpraparat. Med. Klinik., 47, 286.
7.
EvansW.HoyleC. (1933). The comparative value of drugs used in the continuous treatment of angina pectoris. Quart. J. Med., 2, 311.
8.
FoltzE. L.RubinA.SteigerW. A.GazesP. C. (1950). The effects of intravenous aminophylline upon coronary blood-oxygen exchange. Circulation, 2, 215.
9.
GenslerW.GadermannE. (1953). Uber die klinische Anwendung des wasserlöslichen Theophyllinpraparates DHT (Dihydroxypropyltheophyllin). Ther. d. Gegenw., 92, 12.
10.
GilbertN. C.KerrJ. A. (1929). Clinical results in treatment of angina pectoris with the purine-base diuretics. J. Amer. med. Ass., 92, 201.
11.
GoldH.KwitN. T.OttoH. (1937). The xanthines (theobromine and aminophylline) in the treatment of cardiac pain. J. Amer. med. Ass., 108, 2173.
12.
Gold, H. Others Of Cornell Univ. Med. School And New York Hospital (1954). Conference on therapy: How to evaluate a new drug. Amer. J. Med., 17, 722.
13.
GreinerT.GoldH.CattellMcK.TravellJ.BakstH.RinzlerS. H.BenjaminZ. H.WarshawL. J.BobbA. L.KwitN. T.ModellW.Rothend-LerH. H.MesseloffC. R.KramerM. L. (1950). A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort: A study of khellin (Visammin). Ass. J. Med., 9, 143.
14.
HerdanG. (1955). Statistics of therapeutic trials. London. Elsevier Publishing Co., p. 14.
HillR.MelroseA. G. (1953). Khellin in treatment of angina pectoris. Glasg. med. J., 34, 17.
17.
HillerE. (1953). Klinische und oszillographische Untersuchungen. Uber die Wirksamkeit eines neven wasserlöslichen Theophyllinderivate (DHT). Dtsch. med. Wschr., 78, 17.
18.
ManeyP. V.JonesJ. W.GrossE. C.KornsH. M. (1946). Dihydroxypropyltheophylline: Its preparation and pharmacological and clinical study. J. Amer. Pharm. Ass. (Scient. Ed.), 35, 266.
19.
MasterA. M. (1935). Two-step test of myocardial function. Amer. Heart J., 10, 495.
20.
MasterA. M.OppenheimerE. T. (1929). Simple exercise tolerance test for circulatory efficiency with standard tablets for normal individuals. Amer. J. med. Sci., 177, 223.
21.
MasterA. M.JaffeH. L.DackS. (1939). Drug treatment of angina pectoris due to coronary artery disease. Amer. J. med. Sci., 197, 774.
22.
RussekH. I.ZohmanB. L.DrummA. E.WeingartenW.DorsetV. J. (1955). Long-acting coronary vasodilator drugs. Metamine, paveril, nitroglyn and peritrate. Circulation, 12, 169.
23.
SilberE. N.KatzL. N. (1953). Coronary dilators and angina: Reappraisal. J. Amer. med. Ass., 153, 1075.
24.
StaehlerW.HenftlingT. (1952). Klinisch-chururgische Erfahrungen mit DHT (Dihydroxypropyltheophylline). Die Medizinische, 25, 865.
25.
SteinbergF.JensenJ. (1945). On use of theophylline aminoisobutanol in angina pectoris. J. Lab.clin. Med., 30, 769.
26.
WaxlerS. H.SchackJ. A. (1950). Administration of aminophylline (theophylline ethylenediamine). J. Amer. med. Ass., 143, 736.
27.
WinsorT.HumphreysP. (1952). Influence of erythritol tetranitrate (peritrate) on acute and chronic coronary insufficiency. Angiology, 3, 1.
28.
WolfS. W.PinskyR. H. (1954). Effects of placebo administration and occurrence of toxic reactions. J. Amer. med. Ass., 155, 339.
